Rhinorus, 0.05% spray 20 ml

Pharmacotherapeutic group: anticongestinal agent – alpha-adrenomimetic

ATC code: R01AA07

Pharmacodynamics:

Indications

acute rhinitis (including against the background of acute respiratory diseases and allergic rhinitis);
sinusitis;
eustachitis;
runny nose due to allergies and colds;
otitis media (as part of combination therapy to reduce swelling of the nasopharyngeal mucosa);
to facilitate rhinoscopy;
preparing patients for diagnostic manipulations in the nasal passages.

Pharmacological effect

Pharmacotherapeutic group: anticongestive agent – alpha-adrenergic agonist

ATX code: R01AA07

Pharmacodynamics:

Special instructions

Do not exceed recommended doses and do not use for a long time.
Before use, it is necessary to clean the nasal passages.
Should not be used for more than 7 days.

Active ingredient

Xylometazoline

Composition

Active ingredient:

xylometazoline hydrochloride 0.5 mg;

Excipients:

benzalkonium chloride,

sodium chloride,

disodium edetate,

sodium dihydrogen phosphate dihydrate,

sodium hydrogen phosphate dodecahydrate,

eucalyptus oil,

water d/i.

Contraindications

arterial hypertension;
tachycardia;
severe atherosclerosis;
glaucoma;
atrophic rhinitis;
hyperthyroidism;
surgical interventions on the meninges (history);
pregnancy (for nasal drops);
children under 2 years of age;
children under 6 years of age (for nasal drops 0.1% and nasal spray 0.1%);
hypersensitivity to the components of the drug (including eucalyptus oil).

Do not use during therapy with MAO inhibitors and tricyclic antidepressants, as well as with other drugs that increase blood pressure.

The drug should be prescribed with caution for diabetes mellitus, coronary artery disease, angina pectoris of functional class III-IV, prostatic hyperplasia, and during lactation.

Side Effects

Local reactions: with frequent and/or prolonged use – irritation and/or dryness of the nasopharyngeal mucosa, burning, paresthesia, sneezing, hypersecretion; rarely – swelling of the nasal mucosa.

Systemic reactions: vomiting, headache, palpitations, increased blood pressure, insomnia, blurred vision, depression (with long-term use of high doses).

Interaction

It is possible to enhance the systemic effect with simultaneous use of monoamine oxidase inhibitors (MAO) and tricyclic antidepressants.

Overdose

Symptoms: increased side effects.

Treatment: symptomatic under medical supervision.

Storage conditions

In a dry place, protected from light, at a temperature not exceeding 25 ° C.

Shelf life

2 years

Manufacturer

Sintez, Russia